Search - tctmd.com

Displaying 201 - 215 of 215

Sort: Relevancy | Date

Presentation TVT 2014

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Presenter: Susheel Kodali

June 06, 2014

Presentation TVT 2014

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Presenter: Nicolas M. van Mieghem

June 06, 2014

Presentation TVT 2014

Technology Overview and Status of the CLEAN-TAVI Randomized Trial

Presenter: Axel Linke

June 06, 2014

Presentation TVT 2014

Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

Presenter: Alec S. Vahanian

June 06, 2014

Presentation TCT 2013

My Crystal Ball: Procedural Changes (eg, No Predilatation and Cerebral Protection Devices) Will Reduce Strokes After TAVR in the Future

Presenter: Nicolas van Mieghem

October 28, 2013

Presentation TVT 2013

Cerebral Embolic Protection Devices

Presenter: Eberhard Grube

June 14, 2013

Presentation

Risk Factors for Cerebral Embolization After CAS With Embolic Protection

Presenter: L. Bijuklic

June 06, 2013

Presentation TCT 2012

Futuristic TAVR Devices and Cerebral Protection

Presenter: Eberhard Grube

October 25, 2012

Presentation TCT 2012

Cerebral Embolic Protection during TAVR: Metrics for Evaluating Safety and Efficacy

Presenter: Martyn Thomas

October 25, 2012

Presentation TCT 2012

Will Cerebral Embolic Protection Devices Reduce Strokes After TAVR?

Presenter: Samir Kapadia

October 24, 2012

Presentation TCT 2012

TCT-1. Risk Factors for Cerebral Embolization After Carotid Artery Stenting with Embolic Protection – A DW–MRI Study in 827 Patients

Presenter: Klaudija Bijuklic

October 23, 2012

Presentation TVT 2012

Overview of Cerebral Protection Devices

Presenter: Eberhard Grube

June 05, 2012

Presentation TVT 2012

Will Cerebral Embolic Protection Devices Reduce Strokes After TAVR?

Presenter: Josep Rodes-Cabau

June 04, 2012

Presentation TVT 2012

Complication of a Cerebral Protection Device

Presenter: 204222|Ronald Binder

June 02, 2012

Presentation GI2 2012

New Femural Closure Devices, Cerebral Protection and Innovative Valves

Presenter: Alexandre Abizaid

April 11, 2012

Advertisement

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Technology Overview and Status of the CLEAN-TAVI Randomized Trial

Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

My Crystal Ball: Procedural Changes (eg, No Predilatation and Cerebral Protection Devices) Will Reduce Strokes After TAVR in the Future

Cerebral Embolic Protection Devices

Risk Factors for Cerebral Embolization After CAS With Embolic Protection

Futuristic TAVR Devices and Cerebral Protection

Cerebral Embolic Protection during TAVR: Metrics for Evaluating Safety and Efficacy

Will Cerebral Embolic Protection Devices Reduce Strokes After TAVR?

TCT-1. Risk Factors for Cerebral Embolization After Carotid Artery Stenting with Embolic Protection – A DW–MRI Study in 827 Patients

Overview of Cerebral Protection Devices

Will Cerebral Embolic Protection Devices Reduce Strokes After TAVR?

Complication of a Cerebral Protection Device

New Femural Closure Devices, Cerebral Protection and Innovative Valves

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content